Pfizer's RSV vaccine for babies gets greenlight from FDA
Given during the third trimester of pregnancy, Pfizer's new shot protects infants from lower respiratory tract disease caused by RSV
Stay updated with breaking news from Eric Simoes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Given during the third trimester of pregnancy, Pfizer's new shot protects infants from lower respiratory tract disease caused by RSV
The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.
The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.
New shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.
The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.